Skip to main content


Full Schedule

Full Schedule

  • Saturday, October 16, 2021
  • 10:00 AM – 11:00 AM EDT
    An AP Perspective on Infusion Reactions in the Era of Immunotherapy
  • 10:00 AM – 8:30 PM EDT
    Industry Encore Posters
  • 11:15 AM – 12:00 PM EDT
    Sarclisa + KD: An Anti-CD38 Combination for the Treatment of Multiple Myeloma Patients as Early as First Relapse - Sanofi Genzyme
  • 12:00 PM – 1:00 PM EDT
    Conversation Circles: Emotional Intelligence: An AP Growth Tool
  • 12:00 PM – 1:00 PM EDT
    Conversation Circles: Professional Bullying
  • 1:15 PM – 2:00 PM EDT
    Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With Acute Myeloid Leukemia
  • 2:00 PM – 2:30 PM EDT
    Moderated Clinical Posters
  • 2:30 PM – 3:15 PM EDT
    The Advanced Practice Role in Clinical Trials: Past, Present, and Future
  • 3:30 PM – 4:15 PM EDT
    Advances in targeted therapy for CLL: Efficacy and Practical Management of BCL-2 inhibitors - AbbVie Medical Affairs
  • 4:30 PM – 5:15 PM EDT
    New Drug Updates: Investigational Therapeutics in the Pipeline
  • 5:30 PM – 6:15 PM EDT
    In Adult and Pediatric Patients 12 Years and Older with Chronic GVHD, Intervene with JakafiĀ® (ruxolitinib) At the First Sign of Initial Systemic Treatment Failure - Incyte Corporation
  • 6:30 PM – 7:30 PM EDT
    An AP Perspective on Infusion Reactions in the Era of Immunotherapy
  • 7:45 PM – 8:30 PM EDT
    Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With Acute Myeloid Leukemia